Cargando…
Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921581/ https://www.ncbi.nlm.nih.gov/pubmed/35140119 http://dx.doi.org/10.1136/jech-2021-218409 |
| _version_ | 1784669354033414144 |
|---|---|
| author | Barnes-Weise, Julia Santos Rutschman, Ana Adler, Reid |
| author_facet | Barnes-Weise, Julia Santos Rutschman, Ana Adler, Reid |
| author_sort | Barnes-Weise, Julia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8921581 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89215812022-03-25 Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem Barnes-Weise, Julia Santos Rutschman, Ana Adler, Reid J Epidemiol Community Health Commentary BMJ Publishing Group 2022-04 2022-02-09 /pmc/articles/PMC8921581/ /pubmed/35140119 http://dx.doi.org/10.1136/jech-2021-218409 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Commentary Barnes-Weise, Julia Santos Rutschman, Ana Adler, Reid Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem |
| title | Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem |
| title_full | Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem |
| title_fullStr | Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem |
| title_full_unstemmed | Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem |
| title_short | Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem |
| title_sort | assessment of the proposed intellectual property waiver as a mechanism to address the covid-19 vaccine scarcity problem |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921581/ https://www.ncbi.nlm.nih.gov/pubmed/35140119 http://dx.doi.org/10.1136/jech-2021-218409 |
| work_keys_str_mv | AT barnesweisejulia assessmentoftheproposedintellectualpropertywaiverasamechanismtoaddressthecovid19vaccinescarcityproblem AT santosrutschmanana assessmentoftheproposedintellectualpropertywaiverasamechanismtoaddressthecovid19vaccinescarcityproblem AT adlerreid assessmentoftheproposedintellectualpropertywaiverasamechanismtoaddressthecovid19vaccinescarcityproblem |